Search
for
Sort by
Research 391–420 of 1000+
- Mechanisms of autophagy and their implications in dermatological disorders
- The Role of the Gut Microbiome and Microbial Dysbiosis in Common Skin Diseases
- The Role of Janus Kinase Inhibitors in Dermatology
- Skin Disorders in Athletes: Professional and Recreational Sports
- Adverse Reactions to Oral Retinoids An Update
- Gender differences in skin: A review of the literature
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Acquired scalp alopecia. Part II: A review
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Genetic Single Nucleotide Polymorphisms of IL-16 and its Concentration of Patients Infected with Alopecia Areata in Diyala Province, Iraq
- Contents Vol. 2, 2016
- Clinical Management in Psychodermatology
- TOC
- Dermatologic therapy: December 1987 to December 1988
- LB1053 Dysregulation of antioxidant enzyme PRDX5 in alopecia areata
- Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Stratum corneum dysfunction in dandruff
- Off-label uses of retinoids in dermatology
- Prolactin: A Mammalian Stress Hormone and Its Role in Cutaneous Pathophysiology
- Management and Genetics of Alopecia Areata within the USA: A Cross-Sectional Study of All of Us
- Advances in Bioprinting to Model Immune‐Mediated Skin Diseases
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- 519 The role of the leaky gut in the development of alopecia areata
- The microbiome in patients with atopic dermatitis
- The Pathobiology of Skin Aging
- The Role of Exosomes Derived From Mesenchymal Stromal Cells in Dermatology
- Skin inflammation activates intestinal stromal fibroblasts and promotes colitis
- Topical Administration of Drugs Incorporated in Carriers Containing Phospholipid Soft Vesicles for the Treatment of Skin Medical Conditions